T F Bumol
Overview
Explore the profile of T F Bumol including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
402
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lahn M, Sundell K, Gleave M, Ladan F, Su C, Li S, et al.
BJU Int
. 2004 May;
93(7):1076-81.
PMID: 15142167
No abstract available.
2.
Bumol T, Watanabe A
JAMA
. 2001 Feb;
285(5):551-5.
PMID: 11176857
The completion of the first draft of the human genome has provided an unprecedented opportunity to understand the genetic and molecular basis of disease. Parallel developments of new biological technologies,...
3.
Apelgren L, Bailey D, Fouts R, Short L, Bryan N, Evans G, et al.
Cell Immunol
. 1996 Oct;
173(1):55-63.
PMID: 8871601
The MRL lpr/lpr mouse strain is an animal model for the autoimmune disorder systemic lupus erythematosus (SLE). Pathologic changes in the mice include a severe proliferative glomerulonephritis, lymph node and...
4.
Dantzig A, Shepard R, Cao J, Law K, Ehlhardt W, Baughman T, et al.
Cancer Res
. 1996 Sep;
56(18):4171-9.
PMID: 8797588
Overexpression of P-glycoprotein (Pgp) by tumors results in multidrug resistance (MDR) to structurally unrelated oncolytics. MDR cells may be sensitized to these oncolytics when treated with a Pgp modulator. The...
5.
Lin H, Rampersaud A, Archer R, Pawlak J, Beavers L, Schmidt R, et al.
J Med Chem
. 1995 Jan;
38(2):277-88.
PMID: 7830271
A new series of sterols was synthesized and tested in a CHO cell-based LDL receptor/luciferase (LDLR/Luc) assay to investigate the capability of derepressing the transcription of LDL receptor promoter in...
6.
Evans G, Bensch W, Apelgren L, Bailey D, Kauffman R, Bumol T, et al.
J Lipid Res
. 1994 Sep;
35(9):1634-45.
PMID: 7806977
The effects of cholesteryl ester transfer protein (CETP) inhibition on the serum lipoprotein profile in both normocholesterolemic and hypercholesterolemic hamsters has been determined following subcutaneous injection of 12.5 mg/kg of...
7.
Williams J, Bellinger D, Nichols T, Griggs T, Bumol T, Fouts R, et al.
Arterioscler Thromb
. 1993 Apr;
13(4):548-54.
PMID: 8466890
Lipoprotein(a) (Lp[a]) is a newly recognized risk factor for the development of coronary heart disease and stroke in human beings; however, the mechanisms by which Lp(a) increases the risk of...
8.
Hoskins J, DeHerdt S, Moore R, Bumol T
Int J Cancer
. 1993 Feb;
53(4):680-8.
PMID: 8094716
Several novel cell lines with variable resistance to Vinca alkaloids have been derived from the Caco-2 human colorectal carcinoma cell line. Parental Caco-2 cells were found by PCR analysis and...
9.
Schrappe M, Bumol T, Apelgren L, Briggs S, Koppel G, Markowitz D, et al.
Cancer Res
. 1992 Jul;
52(14):3838-44.
PMID: 1617657
A conjugate of 4-desacetylvinblastine-3-carboxyhydrazide (DAVLBHY) and the glioma-reactive monoclonal antibody (mAb) 9.2.27 induced long-term suppression of tumor growth in athymic nude mice engrafted with U87MG human glioma cells. In vitro,...
10.
Petersen B, DeHerdt S, Schneck D, Bumol T
Cancer Res
. 1991 May;
51(9):2286-90.
PMID: 2015593
Monoclonal antibody (MoAb) conjugates have been used to treat a variety of malignancies. The majority of the MoAbs which have been used therapeutically are from murine sources. The infusion of...